Search Results
76 items found for "Keltic Pharma Therapeutics"
- Gallein, G protein βγ subunits inhibitor, suppresses the TGF-α-induced migration of hepatocellular carcinoma cells via inhibition of the c-Jun N-terminal kinase
Small molecules targeting the subunits of Gα and Gβγ have been developed as cancer therapeutics.
- Leukotriene B4 receptor 2 governs macrophage migration during tissue inflammation
demonstrate that BLT2 mediates macrophage migration during inflammation, which implicates it as a potential therapeutic
- Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
Furthermore, their modulation could be considered as a promising approach in lung cancer therapeutics
- Ep 113 with Dr. Prasenjit Saha
receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic
- GPR176 promotes fibroblast-to-myofibroblast transition in organ fibrosis progression
Developing a GPR176 inverse agonist or allosteric modulator is a promising therapeutic approach for fibrosis
- Ep 153 with Dr Jacek Mokrosiński
Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations
- Ep 146 with Dr Michael Feigin
Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic
- Advanced data analysis for GPCR pharmacology
drug action and is known for applying binding and signaling kinetics to the development of effective therapeutics
- GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the synovium
Our results suggest that GPR15/GPR15L have a pathogenic role in RA and their antagonizing could be a therapeutic
- A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages
better understanding of metabolite-sensing GPCRs, such as GPR109A, could establish their potential as therapeutic
- Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone
targeting the Gs-GPCR or components of the downstream signaling pathway could serve as a promising therapeutic
- The orphan G protein-coupled receptor 141 expressed in myeloid cells functions as an inflammation suppressor
controlling the functions of monocytes and dendritic cells and that targeting GPR141 may be a possible therapeutic
- Interplay between G protein-coupled receptors and nanotechnology
understanding of the designated value of GPCRs for molecular engineering of biomaterials with GPCRs in therapeutical
- Investigating isoform switching in RHBDF2 and its role in neoplastic growth in breast cancer
In the past, studies predicting therapeutic drug targets for cancer therapy focused on the assumption
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
understanding the molecular basis for human tumor development and how to use this knowledge to devise new therapeutics Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic
- LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration
Moreover, our findings propose a therapeutic potential in combined CXCR4 and LPA1 inhibitors for cancer
- Ep 148 with Dr Arthur Christopoulos
Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
These findings provide a promising therapeutic approach to selectively induce ferroptosis in glioblastoma
- GPCR Retreat Schedule 2023
San Diego Read More Friday, November 3rd / 3:55 PM Inhibition of Relaxin Autocrine Signaling Confers Therapeutic
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
University of Copenhagen, Copenhagen, Denmark. (2) Department of Psychiatry and Molecular Pharmacology and Therapeutics Columbia University Vagelos College of Physicians and Surgeons, New York, USA; Division of Molecular Therapeutics